Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer

Author： Saad Maha   Garbuzenko Olga B   Minko Tamara  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.3, Iss.6, 2008-12, pp. : 761-776

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multidrug-resistant tuberculosis: Treatment outcome in Denmark, 1992–2007

By Bang Didi   Lillebaek Troels   Thomsen Vibeke Østergaard   Andersen Åse Bengård  

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 4, 2010-03 ,pp. : 288-293

Informa Healthcare

Access to resources Recommend Favorite

Tumor-targeting nanosystems for the delivery of siRNA

By Aigner Achim  

Nanomedicine, Vol. 2, Iss. 4, 2007-08 ,pp. : 569-572

Future Medicine

Access to resources Recommend Favorite

Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy

By Mcgready R.   Cho T.   Hkirijaroen L.   Simpson J.   Chongsuphajaisiddhi T.   White N. J.   Nosten F  

Annals of Tropical Medicine and Parasitology, Vol. 92, Iss. 6, 1998-09 ,pp. : 643-653

Routledge Ltd

Access to resources Recommend Favorite

Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa

By Marais E.   Mlambo C.   Lewis J.   Rastogi N.   Zozio T.   Grobusch M.   Duse A.   Victor T.   Warren R.  

Infection, Vol. 42, Iss. 2, 2014-04 ,pp. : 405-413

Springer Publishing Company

Access to resources Recommend Favorite

Impact of Diabetes on Treatment Outcomes and Long-Term Survival in Multidrug-Resistant Tuberculosis

By  

Respiration, Vol. 86, Iss. 6, 2013-05 ,pp. : 472-478

Karger

Access to resources Recommend Favorite